Commentary: lactate-induced glucose output is unchanged by metformin at a therapeutic concentration a mass spectrometry imaging study of the perfused rat liver
Remember that the goal of obesity treatment is safe, sustainable weight loss that improves overall health, and this is most likely to be achieved through evidence-based approaches supported by clinical research
When your prescribed dose does not match a clean unit number Real-world dosing does not always produce clean numbers
Fat loss and muscle improvements require sustained GH elevation over weeks, not days
Sleep, hydration, and electrolytes matter here

Reference comparisons: - Brand Zepbound at Eli Lilly list price: roughly $1,060/month - Brand Zepbound with Lilly savings card (commercial insurance, not covered): roughly $550/month - LillyDirect self-pay (FDA-approved Zepbound shipped directly): roughly $350-$550/month depending on dose - Commercial insurance copay for covered Zepbound (uncommon for obesity indication): roughly $25-$100/month Competitor telehealth pricing for compounded tirzepatide: - Henry Meds: roughly $300/month flat for compounded tirzepatide (verify current) - Ivim Health: roughly $270-$370/month by dose and term - Mochi Health: roughly $260-$375/month - Vitastir: roughly $200-$400/month - Form Health: roughly $350-$450/month (broader clinical scope) Hidden costs to account for when comparing Citizen Meds to alternatives: - Dose escalation charges: some providers charge a per-escalation consultation fee, others include it - Injection supplies: most providers include syringes and alcohol swabs but confirm - Cold-chain shipping surcharges in hot months or rural areas - Required lab work: some services require baseline or periodic labs at your expense Value math: If insurance covers brand Zepbound at a low copay, brand is almost always the right move: FDA-approved, stability data, standardized across every fill
